Altre lingue Ziccum AB

Azioni

ZICC

SE0011415595

Tempo differito Nasdaq Stockholm Altri mercati azionari 12:52:25 10/07/2024			Variaz. 5gg	Var. 1 gen.
5,56 ^SEK	+3,73%		-3,47%	-27,42%

19/06	Ziccum firma un Accordo di valutazione con Recode Therapeutics per lo studio sull'mRNA di LaminarPace	CI
29/04	Ziccum AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Analyst interview with Ziccum's CEO on new project and expanding business dialogues	02/07
Ziccum calls for a second investment tranche in accordance with its financing agreement with GCF	25/06
Ziccum signs Evaluation agreement with ReCode Therapeutics for LaminarPace mRNA study	19/06
Ziccum Signs Evaluation Agreement with Recode Therapeutics for LaminarPace mRNA Study	19/06
Ziccum reports on developments in the portfolio of industry partner projects	11/06
Exercise of Employee Stock Options of Series LTI 2021:1 at Ziccum AB (publ)	03/06
Bulletin from the Annual General Meeting of Ziccum AB (publ)	29/05
Ziccum partners with Dagens Industri for Investor Relations program	28/05
Ziccum CEO Analyst video interview: Q1, 2024 highlights	06/05
Ziccum AB strengthens patent portfolio with three solid data PCT applications according to expanded IP strategy	30/04
Ziccum AB (publ) Interim report Q1 2024	29/04
Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Ziccum contracts RFR Solutions for GMP manufacturing in next phase of technology scale-out	26/04
Ziccum AB (publ) releases Annual Report 2023	15/04
Ziccum CEO to present at first annual event for Biopharma/Biotech disruptors hosted by major US bank in New York City	10/04
Ziccum strengthens and streamlines business and finance functions	03/04
Ziccum inhalable mRNA/LNP project confirms excellent properties obtained by LaminarPace	14/03
Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace	14/03
Ziccum reports significant progress in 3D-modelling project with model completion	01/03
Ziccum AB and project partner Zurich institute of Applied Sciences Updates LaminarPace Simulation Project Progress and Findings	01/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ziccum AB

Azioni

ZICC

SE0011415595

Altre lingue

Filtri